MRNA 8-K 2026-09-30

Moderna, Inc. (MRNA) 8-K dated 2026-09-30 — accession 0001193125-26-408289. This URL is the filing, not the MRNA hub.

Moderna, Inc. (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..

Moderna, Inc. filed a 8-K on 2026-09-30. Accession 0001193125-26-408289.

Cached items: 5.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.

Not investment advice. The MRNA SEC hub lists recent forms. The stock page is the research view.